Trial Profile
Precision-IV
Status:
Planning
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 18 May 2007
Price :
$35
*
At a glance
- Drugs Doxorubicin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms Precision-IV
- 18 May 2007 New trial record.